Showing results (1-10 of 134) with videos related to
Sort By:
Pageof 14
The Urologic Clinics of North America|April 16, 2022
Pharmacotherapy for Erectile Dysfunction in 2021 and BeyondFarnoosh Nik-Ahd, Alan W ShindelStem Cells (Dayton, Ohio)|April 23, 2014
Ex vivo gene editing of the dystrophin gene in muscle stem cells mediated by peptide nucleic acid single stranded oligodeoxynucleotides induces stable expression of dystrophin in a mouse model for Duchenne muscular dystrophyFarnoosh Nik-Ahd, Carmen BertoniCurrent Urology Reports|September 15, 2018
Recurrent Urinary Tract Infections in Females and the Overlap with Overactive BladderFarnoosh Nik-Ahd, A Lenore Ackerman, Jennifer AngerEuropean Urology Focus|July 7, 2026
Self-management of Male LUTSFarnoosh Nik-Ahd, Mohammad Albarqouni, Scott R Bauer, et al.Journal of Cardiovascular Electrophysiology|May 20, 2018
Electrophysiology and structural interventions in adults with congenital heart disease: Comparison of combined versus separate proceduresIan Lindsay, Farnoosh Nik-Ahd, Jamil A Aboulhosn, et al.Urology Practice|May 5, 2023
Population Trends in Frailty in Older Adults with Benign Urological Conditions in Northern CaliforniaFarnoosh Nik-Ahd, Chengshi Jin, W John Boscardin, et al.International Urogynecology Journal|January 9, 2019
Robotic sacrocolpopexy: adverse events reported to the FDA over the last decadeColby Souders, Farnoosh Nik-Ahd, Hanson Zhao, et al.The Journal of Sexual Medicine|September 7, 2019
Anejaculation: Relevance to Sexual Enjoyment in Men and WomenAlan W ShindelThe Journal of Sexual Medicine|September 9, 2009
2009 update on phosphodiesterase type 5 inhibitor therapy part 2: updates on optimal utilization for sexual concerns and rare toxicities in this classAlan W ShindelThe Journal of Sexual Medicine|July 7, 2009
2009 update on phosphodiesterase type 5 inhibitor therapy part 1: Recent studies on routine dosing for penile rehabilitation, lower urinary tract symptoms, and other indications (CME)Alan W ShindelPageof 14